Cargando…

Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth

Liver cirrhosis is a common chronic disease in China. The effect of modified Xianglian Pingwei powder plus Western medicine in the treatment of liver cirrhosis and positive small intestinal bacterial overgrowth is promising. Totally, 100 patients with liver cirrhosis and positive intestinal bacteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Shanshan, Wang, Qingqing, Wei, Fang, Zheng, Guoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017475/
https://www.ncbi.nlm.nih.gov/pubmed/35449813
http://dx.doi.org/10.1155/2022/5063088
_version_ 1784688773718605824
author Su, Shanshan
Wang, Qingqing
Wei, Fang
Zheng, Guoqi
author_facet Su, Shanshan
Wang, Qingqing
Wei, Fang
Zheng, Guoqi
author_sort Su, Shanshan
collection PubMed
description Liver cirrhosis is a common chronic disease in China. The effect of modified Xianglian Pingwei powder plus Western medicine in the treatment of liver cirrhosis and positive small intestinal bacterial overgrowth is promising. Totally, 100 patients with liver cirrhosis and positive intestinal bacterial overgrowth in Cangzhou Central Hospital from February 2020 to February 2021 were enrolled and randomized via the random number table method at a ratio of 1 : 1 into the study group and control group. The control group received glutathione and levofloxacin hydrochloride, and the study group received Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride. The traditional Chinese medicine (TCM) syndrome scores, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin (TBIL) levels of the two groups were decreased after treatment with lower results in the study group. Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride was associated with a significantly lower positive rate of small intestine bacterial growth, serum endotoxin level, and peripheral blood toll-like receptor 2 (TLR2) and TRL4 levels versus glutathione and levofloxacin hydrochloride. The combined medication achieved a higher efficacy (90.00%) versus glutathione and levofloxacin hydrochloride (66.00%). The two groups experienced similar safety. Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride achieved significant benefits of clinical efficacy with a high safety profile in patients with liver cirrhosis versus glutathione and levofloxacin hydrochloride.
format Online
Article
Text
id pubmed-9017475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90174752022-04-20 Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth Su, Shanshan Wang, Qingqing Wei, Fang Zheng, Guoqi Evid Based Complement Alternat Med Research Article Liver cirrhosis is a common chronic disease in China. The effect of modified Xianglian Pingwei powder plus Western medicine in the treatment of liver cirrhosis and positive small intestinal bacterial overgrowth is promising. Totally, 100 patients with liver cirrhosis and positive intestinal bacterial overgrowth in Cangzhou Central Hospital from February 2020 to February 2021 were enrolled and randomized via the random number table method at a ratio of 1 : 1 into the study group and control group. The control group received glutathione and levofloxacin hydrochloride, and the study group received Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride. The traditional Chinese medicine (TCM) syndrome scores, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin (TBIL) levels of the two groups were decreased after treatment with lower results in the study group. Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride was associated with a significantly lower positive rate of small intestine bacterial growth, serum endotoxin level, and peripheral blood toll-like receptor 2 (TLR2) and TRL4 levels versus glutathione and levofloxacin hydrochloride. The combined medication achieved a higher efficacy (90.00%) versus glutathione and levofloxacin hydrochloride (66.00%). The two groups experienced similar safety. Xianglian Pingwei powder plus glutathione and levofloxacin hydrochloride achieved significant benefits of clinical efficacy with a high safety profile in patients with liver cirrhosis versus glutathione and levofloxacin hydrochloride. Hindawi 2022-04-11 /pmc/articles/PMC9017475/ /pubmed/35449813 http://dx.doi.org/10.1155/2022/5063088 Text en Copyright © 2022 Shanshan Su et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Su, Shanshan
Wang, Qingqing
Wei, Fang
Zheng, Guoqi
Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title_full Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title_fullStr Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title_full_unstemmed Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title_short Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth
title_sort effect of modified xianglian pingwei powder plus glutathione and levofloxacin hydrochloride on patients with liver cirrhosis and positive small intestinal bacterial overgrowth
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017475/
https://www.ncbi.nlm.nih.gov/pubmed/35449813
http://dx.doi.org/10.1155/2022/5063088
work_keys_str_mv AT sushanshan effectofmodifiedxianglianpingweipowderplusglutathioneandlevofloxacinhydrochlorideonpatientswithlivercirrhosisandpositivesmallintestinalbacterialovergrowth
AT wangqingqing effectofmodifiedxianglianpingweipowderplusglutathioneandlevofloxacinhydrochlorideonpatientswithlivercirrhosisandpositivesmallintestinalbacterialovergrowth
AT weifang effectofmodifiedxianglianpingweipowderplusglutathioneandlevofloxacinhydrochlorideonpatientswithlivercirrhosisandpositivesmallintestinalbacterialovergrowth
AT zhengguoqi effectofmodifiedxianglianpingweipowderplusglutathioneandlevofloxacinhydrochlorideonpatientswithlivercirrhosisandpositivesmallintestinalbacterialovergrowth